Valuation: 10x Genomics, Inc.

Market Cap 9.98B 8.7B 8.22B 7.46B 13.98B 958B 14.04B 98.43B 37.99B 487B 37.49B 36.66B 1,567B P/E 2026 *
-107x
P/E 2027 * -111x
Enterprise Value 9.52B 8.3B 7.83B 7.11B 13.33B 913B 13.39B 93.85B 36.22B 464B 35.74B 34.95B 1,494B EV / Sales 2026 *
15.3x
EV / Sales 2027 * 13.9x
Free-Float
90.92%
Yield 2026 *
-
Yield 2027 * -
1 day-0.48%
1 week+11.68%
Current month+22.66%
1 month+37.70%
3 months+120.40%
6 months+341.50%
Current year+369.65%
1 week 64.73
Extreme 64.73
79.94
1 month 58.7
Extreme 58.7
79.94
Current year 15.9
Extreme 15.9
79.94
1 year 11.16
Extreme 11.16
79.94
3 years 6.78
Extreme 6.78
79.94
5 years 6.78
Extreme 6.78
187.85
10 years 6.78
Extreme 6.78
208.99
Manager TitleAgeSince
Chief Executive Officer 49 2012-07-01
President 51 2012-09-30
Director of Finance/CFO 51 2024-08-11
Director TitleAgeSince
Director/Board Member 51 2012-07-01
Director/Board Member 49 2012-07-01
Chairman 68 2013-07-31
Date Insider Type Main position Quantity % Market Cap. Importance
9/9/26 Sell

Chief Financial Officer

-46,388 0.0386%
9/3/26 Sell

Chairman

-20,000 0.0166%
9/1/26 Don

Founder

-100 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-0.48%+11.68%+477.24%+65.84% 9.98B
-2.03%+13.98%+205.07%+530.73% 24.07B
-0.69%+1.70%-37.14%-21.66% 9.66B
-3.04%+23.17%-10.32% - 8.47B
-0.25%+0.30%+95.02%+56.86% 6.56B
-0.29%+1.58%-28.63%-23.53% 5.74B
+0.47%+4.39%-3.01%-15.77% 4.35B
+2.83%+1.17%+60.35%+69.13% 3.89B
+0.03%+3.31%-20.59%-31.39% 2.74B
+0.23%-10.42% - - 1.55B
Average -0.32%+5.19%+82.00%+78.78% 7.7B
Weighted average by Cap. -0.99%+9.07%+130.87%+202.63%

Financials

2026 *2027 *
Net sales 620M 541M 511M 464M 869M 59.49B 872M 6.12B 2.36B 30.25B 2.33B 2.28B 97.33B 680M 593M 560M 508M 953M 65.26B 957M 6.71B 2.59B 33.18B 2.55B 2.5B 107B
Net income -94.29M -82.22M -77.64M -70.5M -132M -9.05B -133M -930M -359M -4.6B -354M -346M -14.8B -88.67M -77.32M -73.01M -66.3M -124M -8.51B -125M -875M -337M -4.33B -333M -326M -13.92B
Net Debt -465M -405M -383M -348M -651M -44.62B -654M -4.59B -1.77B -22.68B -1.75B -1.71B -72.99B -521M -454M -429M -389M -730M -49.99B -733M -5.14B -1.98B -25.41B -1.96B -1.91B -81.77B
Logo 10x Genomics, Inc.
10x Genomics, Inc. is a life science technology company. The Company's integrated research solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems. Its products are used across diverse fields, from cancer research and immunology to neuroscience and developmental biology. Its commercial product portfolio is made up of its Single Cell and Spatial solutions. Its products include its instruments, which include its Chromium instruments, its Visium CytAssist and its Xenium Analyzer, and its consumables, which include proprietary microfluidic chips, slides, reagents and other consumables for its Single Cell and Spatial solutions. It bundles its software with these products to guide customers through the workflow, from sample preparation through analysis and visualization. It also provides post-warranty service contracts for its instruments.
Employees
1,178
Date Price Change Volume
26-09-18 US$76.60 -0.48% 2,887,167
26-09-17 US$76.97 +5.90% 3,142,992
26-09-16 US$72.68 -2.30% 4,082,634
26-09-15 US$74.39 +6.10% 2,905,279
26-09-14 US$70.11 +2.22% 3,364,058
Trader
Investor
-
Global
-
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
76.60USD
Average target price
52.13USD
Spread / Average Target
-31.94%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!